Absence of Malonyl Coenzyme A Decarboxylase in Mice Increases Cardiac Glucose Oxidation and Protects the Heart From Ischemic Injury
暂无分享,去创建一个
K. Jishage | J. Dyck | G. Lopaschuk | S. Bonnet | M. Young | E. Michelakis | Y. Kawase | T. Hopkins | Miho Watanabe
[1] J. Dyck,et al. Distinct transcriptional regulation of long-chain acyl-CoA synthetase isoforms and cytosolic thioesterase 1 in the rodent heart by fatty acids and insulin. , 2006, American journal of physiology. Heart and circulatory physiology.
[2] M. Durán,et al. Brain abnormalities in a case of malonyl-CoA decarboxylase deficiency. , 2006, Molecular genetics and metabolism.
[3] M. Chandler,et al. Malonyl-CoA decarboxylase inhibition suppresses fatty acid oxidation and reduces lactate production during demand-induced ischemia. , 2005, American journal of physiology. Heart and circulatory physiology.
[4] D. Chace,et al. Cardiomyopathy and Hypotonia in a 5-Month-Old Infant with Malonyl-CoA Decarboxylase Deficiency: Potential for Preclinical Diagnosis with Expanded Newborn Screening , 2005, Pediatric Cardiology.
[5] William C Stanley,et al. Myocardial substrate metabolism in the normal and failing heart. , 2005, Physiological reviews.
[6] Vincenzo Lionetti,et al. Carnitine palmitoyl transferase-I inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure. , 2005, Cardiovascular research.
[7] M. Bray,et al. Diurnal variations in the responsiveness of cardiac and skeletal muscle to fatty acids. , 2004, American journal of physiology. Endocrinology and metabolism.
[8] E. Abel,et al. Evidence for mitochondrial thioesterase 1 as a peroxisome proliferator-activated receptor-alpha-regulated gene in cardiac and skeletal muscle. , 2004, American journal of physiology. Endocrinology and metabolism.
[9] S. K. Woo,et al. Maturation of TonEBP expression in developing rat kidney. , 2004, American journal of physiology. Renal physiology.
[10] J. Dyck,et al. Dichloroacetate Prevents and Reverses Pulmonary Hypertension by Inducing Pulmonary Artery Smooth Muscle Cell Apoptosis , 2004, Circulation research.
[11] Michael D. Schneider,et al. Cardiomyocyte-restricted peroxisome proliferator-activated receptor-δ deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy , 2004, Nature Medicine.
[12] M. Chandler,et al. Malonyl Coenzyme A Decarboxylase Inhibition Protects the Ischemic Heart by Inhibiting Fatty Acid Oxidation and Stimulating Glucose Oxidation , 2004, Circulation research.
[13] M. Prentki,et al. A role for the malonyl-CoA/long-chain acyl-CoA pathway of lipid signaling in the regulation of insulin secretion in response to both fuel and nonfuel stimuli. , 2004, Diabetes.
[14] G. Lopaschuk,et al. Fatty Acid Translocase/CD36 Deficiency Does Not Energetically or Functionally Compromise Hearts Before or After Ischemia , 2004, Circulation.
[15] David Millington,et al. Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance , 2004, Nature Medicine.
[16] M. Lane,et al. Hypothalamic malonyl-CoA as a mediator of feeding behavior , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[17] D. Fitzpatrick,et al. MLYCD mutation analysis: Evidence for protein mistargeting as a cause of MLYCD deficiency , 2003, Human mutation.
[18] M. Holness,et al. Control of cardiac pyruvate dehydrogenase activity in peroxisome proliferator-activated receptor-alpha transgenic mice. , 2003, American journal of physiology. Heart and circulatory physiology.
[19] R. Wolfe,et al. Malonyl coenzyme A and the regulation of functional carnitine palmitoyltransferase-1 activity and fat oxidation in human skeletal muscle. , 2002, The Journal of clinical investigation.
[20] G. Lopaschuk,et al. Malonyl CoA control of fatty acid oxidation in the ischemic heart. , 2002, Journal of molecular and cellular cardiology.
[21] G. Ronnett,et al. C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[22] P. Razeghi,et al. Clock Genes in the Heart: Characterization and Attenuation With Hypertrophy , 2001, Circulation research.
[23] K. Bulmer,et al. Fuel-sensing mechanisms integrating lipid and carbohydrate utilization. , 2001, Biochemical Society transactions.
[24] W. Stremmel,et al. Fatty acid transporters in plasma membranes of cardiomyocytes in patients with dilated cardiomyopathy. , 2000, European journal of medical research.
[25] G. Lopaschuk,et al. Characterization of cardiac malonyl-CoA decarboxylase and its putative role in regulating fatty acid oxidation. , 1998, American journal of physiology. Heart and circulatory physiology.
[26] J. Williams,et al. A new case of malonyl coenzyme A decarboxylase deficiency presenting with cardiomyopathy , 1997, European Journal of Pediatrics.
[27] J. McGarry,et al. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. , 1997, European journal of biochemistry.
[28] J. Mccormack,et al. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions Potential for pharmacological interventions , 1997 .
[29] Bin Liu,et al. Cardiac efficiency is improved after ischemia by altering both the source and fate of protons. , 1996, Circulation research.
[30] G. Lopaschuk,et al. High Rates of Fatty Acid Oxidation during Reperfusion of Ischemic Hearts Are Associated with a Decrease in Malonyl-CoA Levels Due to an Increase in 5′-AMP-activated Protein Kinase Inhibition of Acetyl-CoA Carboxylase (*) , 1995, The Journal of Biological Chemistry.
[31] D. Moore,et al. The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[32] L. Witters,et al. Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart. , 1993, The Journal of biological chemistry.
[33] E. Saggerson,et al. Malonyl-CoA metabolism in cardiac myocytes and its relevance to the control of fatty acid oxidation. , 1993, The Biochemical journal.
[34] R. Kaul,et al. Malonic aciduria and cardiomyopathy , 1993, Journal of Inherited Metabolic Disease.
[35] L. Opie,et al. Protons in ischemia: where do they come from; where do they go to? , 1991, Journal of molecular and cellular cardiology.
[36] G. Lopaschuk,et al. Glucose and palmitate oxidation in isolated working rat hearts reperfused after a period of transient global ischemia. , 1990, Circulation research.
[37] R. Moreno-Sánchez,et al. Dependence of cardiac mitochondrial pyruvate dehydrogenase activity on intramitochondrial free Ca2+ concentration. , 1988, The Biochemical journal.
[38] A. Liedtke,et al. Changes in Substrate Metabolism and Effects of Excess Fatty Acids in Reperfused Myocardium , 1988, Circulation research.
[39] J. McGarry,et al. The role of malonyl-coa in the coordination of fatty acid synthesis and oxidation in isolated rat hepatocytes. , 1978, The Journal of biological chemistry.
[40] R. Hansford,et al. Relative importance of pyruvate dehydrogenase interconversion and feed-back inhibition in the effect of fatty acids on pyruvate oxidation by rat heart mitochondria. , 1978, Archives of biochemistry and biophysics.
[41] M. Oliver,et al. Relation between serum-free-fatty acids and arrhythmias and death after acute myocardial infarction. , 1968, Lancet.
[42] R. Lerch,et al. Myocardial fatty acid oxidation during ischemia and reperfusion , 2005, Molecular and Cellular Biochemistry.
[43] K. Gibson,et al. Cloning and mutational analysis of human malonyl-coenzyme A decarboxylase. , 1999, Journal of lipid research.